Engaged Capital 13F, Q2 2025

Glenn Welling · quarter ending 30 June 2025 · filed 14 August 2025 · SEC CIK 1559771

$357.62M
Filed US book
7
Positions
19.1%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed.

Largest positions, Q2 2025

Weights are against the whole filed book. Changes are in shares held, against the Q1 2025 filing.

CompanyTickerValue% of bookvs Q1 2025
YETI HLDGS INCYETI$68.16M19.1%+40% shares
EVOLENT HEALTH INCEVH$65.92M18.4%+13% shares
V F CORPVFC$63.65M17.8%unchanged
PORTILLOS INCPTLO$56.39M15.8%-12% shares
GXO LOGISTICS INCORPORATEDGXO$43.68M12.2%unchanged
FRESHPET INCFRPT$42.08M11.8%new
BRC INCBRCC$17.73M5.0%unchanged

What changed since Q1 2025

Against the Q1 2025 filing, Engaged Capital opened 1 new position, added to 2, trimmed 1, left 3 unchanged and exited 3. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.

New positions

Exited

Added to

Trimmed

Other quarters

Source: SEC Form 13F-HR, accession 0000921895-25-002274, filed by Engaged Capital LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.